Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
CerTest Biotec is a leading Spanish biotechnology company specializing in the development and manufacture of high-quality in vitro diagnostic products for infectious diseases. Its portfolio includes immunoassays, molecular diagnostic kits such as VIASURE®, raw materials like recombinant proteins and monoclonal antibodies, as well as an emerging focus on RNA-based therapeutics through its Certest Pharma division. The company’s products are sold in over 120 countries. It has received multiple national innovation awards and continues to expand its R&D capabilities with significant investments in new facilities. The clinical results of their IVDs are recognized for reliability but specific trial data are not publicly detailed; the pharma pipeline appears preclinical.[1][2][4][5]
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on CerTest Biotec.